Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis - Ceelen, W; Van Nieuwenhove, Y; Putte, D V; Pattyn, P (Ann Surg Oncol, 2014)